ID   YBT-5
AC   CVCL_YJ20
DR   Wikidata; Q98136386
RX   PubMed=31701557;
CC   Population: Chinese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=31701557).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=31701557
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,20
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 13,20
ST   D19S433: 15,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 14,17
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 21,24
ST   vWA: 14,19
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
RX   PubMed=31701557; DOI=10.1002/hon.2686;
RA   Wang Z.-H., Shi Y.-J., Liu H.-H., Liang Z.-Y., Zhu Q., Wang L.-H.,
RA   Tang B., Miao S.-C., Ma N., Cen X.-N., Ren H.-Y., Dong Y.-J.;
RT   "Establishment and characterization of a DOT1L inhibitor-sensitive
RT   human acute monocytic leukemia cell line YBT-5 with a novel
RT   KMT2A-MLLT3 fusion.";
RL   Hematol. Oncol. 37:617-625(2019).
//